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ABSTRACT 
 
The activation of peroxynitrite (PN) by 
hemoproteins, which leads to its detoxification 
or on the contrary to the enhancement of its 
cytotoxic activity, is a reaction of 
physiological importance that is still poorly 
understood. It has been known for some years 
that the reaction of hemoproteins, notably 
cytochrome P450, with PN leads to the build-
up of an intermediate species with a Soret band 
at ~435 nm (I435). The nature of this 
intermediate is however debated. On the one 
hand, I435 has been presented as a Compound-
II species that can be photo-activated to 
Compound I. A competing alternative involves 
the assignment of I435 to a ferric-nitrosyl 
species. Alike the cytochromes P450, the 
build-up of I435 occurs in NO-synthases 
(NOSs) upon their reaction with excess PN. 
Interestingly, the NOS isoforms vary in their 
capacity to detoxify/activate PN although they 
all show the build-up of I435. To better 
understand PN activation/detoxification by 
heme proteins, a definitive assignment of I435 
is needed. Here we used a combination of fine 
kinetic analysis under specific conditions (pH, 
PN concentrations and PN/NOSs ratios) to 
probe the formation of I435. These studies 
revealed that I435 is not formed upon 
homolytic cleavage of the O-O bond of PN but 
that it arises from side-reactions associated 
with excess PN. Characterization of I435 by 
resonance Raman spectroscopy allowed its 
identification as a ferric iron-nitrosyl complex.  
Together, our study indicates that the model 
used so far to depict PN interactions with 
hemo-thiolate proteins, i.e. leading to the 
formation and accumulation of Compound II, 
needs to be reconsidered. 
 
INTRODUCTION 
 
The interaction between peroxynitrite (PN) and 
hemoproteins is one of the key-aspect to 
understand the biochemical fate and the 
biological activity of PN in vivo [1-3]. This is 
particularly true for NO-synthases (NOSs) that 
are the primary source of PN, and probably 
their primary target [4]. We recently 
highlighted the complexity of this interaction 
that can alternatively lead to the detoxification 
of PN or to the enhancement of its cytotoxic 
effect [5].   
The reaction between PN and hemoproteins 
has been investigated for more than fifteen 
years [6-10]. The series of work devoted to 
hemo-thiolate proteins, such as NOS and 
cytochrome P450, showed the recurrent 
formation of an intermediate species with a 
Soret absorption around 432 - 440 nm (named 
I435 through this manuscript) that is associated 
with an increase of the nitration potency of PN 
[4, 9, 11, 12]. This led to a commonly accepted 
mechanism that involved the homolytic 
cleavage of the PN O-O bond and the release 
of nitrogen dioxide (NO2°, Scheme 1 – red 
arrows) with the concomitant build-up of a 
reaction intermediate identified as an oxoferryl 
species. This intermediate was later assigned to 
a Compound II species (Cpd-II) by Newcomb 
and colleagues when analyzing the interaction 
of PN with various cytochromes P450s [13-
16]. This putative Cpd-II generated by the 
reaction of various P450 with PN was 
photoreduced to an intermediate that was 
somewhat competent for catalysis [15, 17]. 
The assignment of I435 to Cpd-II was however 
contested by Green and coworkers who 
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proposed that the I435 intermediate was an 
iron-nitrosyl complex[18].  
In this regard we also raised concerns about the 
mechanism of PN activation by hemo-thiolate 
proteins. We have initiated a study of the 
interaction of PN with various NOS isoforms 
[5]. Not surprisingly, our results have proven 
so far to be quite similar to the ones obtained 
for CYPs [8, 9, 12, 19], and various 
peroxidases [7] [20]. Indeed, all NOS
 
Scheme 1. Various reaction pathways for the decomposition of peroxynitrite by hemoproteins. Scheme 1 gives an example of 
the large diversity of redox reactions that might take place during the interaction of excess peroxynitrite with hemoproteins. 
Red arrows represent the pathway that has been proposed for peroxynitrite activation by hemo-thiolate proteins such as 
cytochromes P450. Green arrows represent the pathway for NO dioxygenation and peroxynitrite isomerization by globins. 
Blue arrows show a pathway involving the reactions from N-bound peroxynitrite (see Main Text for references). 
 
isoforms showed the same build-up of the I435 
intermediate upon reaction with PN [4]. 
However, the outcome of this reaction varies 
among NOSs; from isomerization of PN, 
which releases nitrate, to PN activation, which 
releases NO2°. This apparent absence of 
relationship between the observed nitration 
pattern by PN and the build-up of the I435 
intermediate raises the question of the nature 
of this intermediate. 
This work aims to clarify the current debate on 
the nature of the I435 intermediate and the 
molecular mechanism of PN activation by 
hemo-thiolate proteins. For this purpose, we 
combined two complementary approaches: i) a 
fine kinetic analysis focusing on the early 
phases of the reaction and on some important 
reaction conditions (pH, PN concentrations, 
PN/NOS molar ratios) and ii) characterization 
of the I435 intermediate by using a T-mixer 
device for its formation coupled to resonance 
Raman spectroscopy for detection. 
Resonance Raman spectroscopy is a very 
appropriate technique to characterize I435. It is 
a sensitive probe of the oxidation, coordination 
and spin states of the heme as well as to the 
nature of the heme axial ligands [21, 22]. 
Notably, the identity of a particular heme 
ligand can be validated using isotopic 
substitution. In NOSs, the proximal ligand 
involves the sulfur atom of a cysteine while the 
distal ligand would be O2, or one of its derived 
activated states such as oxy-ferryl, as well as 
other usual heme ligands such as CO and NO.  
By obtaining the time-resolved resonance 
Raman spectrum of I435 in conditions directly 
comparable to those used for stopped-flow 
experiments, our results suggest that this 
intermediate is not an oxoferryl complex but 
rather an iron-nitrosyl complex as first 
suggested by Green and coworkers. Together, 
the results from these kinetic and spectroscopic 
studies indicate that the model that has been 
used so far to depict PN/hemo-thiolate 
interactions must be reconsidered. 
 
EXPERIMENTAL PROCEDURES 
Chemicals – All chemicals were purchased 
from Sigma or Aldrich Chemical Corp. 
(Sigma-Aldrich, St. Louis, MO, USA) except 
dihydrorhodamine (DHR) and rhodamine that 
were purchased from Calbiochem (EMD 
Biosciences, Inc., San Diego, CA, USA) and 
peroxynitrite (PN) that was purchased from 
Cayman Chemical (Cayman, Ann Arbor, MI, 
USA). PN solutions (between 37 and 45 µM in 
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NaOH 0.3 M) were stored as small (50-100 
µL) aliquots at –80°C. Immediately before 
each experiment, PN concentration was 
measured by UV-visible spectroscopy (ε = 
1670 M
-1
cm
-1
 at 302 nm). Argon (Ar) gas was 
purchased from Messer (Messer France SA, 
Asnières, France and Paxair, Canada). Nitric 
oxide was from Praxair, Canada.  
Enzyme preparation – Wild-type iNOS 
oxygenase domains (iNOSoxy) containing a 
six-histidine tag at its C-terminus was 
expressed in E. Coli BL21 using the PCWori 
vector as already described [23, 24]. saNOS 
was expressed from the cloned gene in frame 
with a C-terminal six-histidine tag [25]. All 
proteins were purified in the absence of 
tetrahydrobiopterin (H4B) and L-arginine (Arg) 
using Ni
2+
-nitrilotriacetate affinity 
chromatography as reported previously[23, 25, 
26]. iNOS concentration was determined by 
the absorbance at 444 nm of the heme ferrous-
CO complex (Fe
II
CO; ε444 = 74 mM
-1
.cm
-1
 
[27]). saNOS concentration was determined 
from the pyridine-hemochrome method [28]. 
Stopped-flow experiments – iNOSoxy and 
saNOS were incubated in the absence of Arg 
and H4B in a fresh anaerobized 100 mM KPi, 
300 µM DTPA degassed buffer at the desired 
pH value. PN solutions were prepared shortly 
before use by diluting a fresh stock solution in 
anaerobized NaOH 0.01 N. Enzyme solutions 
were rapidly mixed to with PN solutions at 
20°C. The mixing sequence gave a set of final 
concentrations of PN and NOSs. The pH of 
such solutions was verified after mixing and 
only negligible variations were noticed. Rapid-
sampling stopped-flow experiments with 
iNOSoxy were performed on a Biologic (Bio-
Logic Science Instruments SA, CLAIX, 
France) SFM 300 instrument coupled via a 
fiber optic cable with a Tidas spectrograph 
(WPI Inc., Sarasota, FL, USA) equipped with a 
rapid-sampling 1024 diode array detector 
(3 ms/spectrum). The light source was a 150 W 
Xe lamp. The spectral range of the 
monochromator was set from 200-1015 nm 
and the spectral resolution was 2 nm 
(0.8 nm/diode). Wavelength accuracy is quoted 
by the manufacturer to be 0.1 nm. A total of 
750 UV-visible optical absorption spectra were 
recorded at various time intervals to 
encompass the whole kinetic reactions (3 and 
40 seconds range). The apparatus dead-time 
was estimated to be less than 2 ms. The 
stopped-flow apparatus used to characterize 
the reaction of saNOS with PN is described in 
Supporting Information. The above protocol 
was adapted to the following types of 
experiments. 
Kinetics of PN decay – These kinetics were 
investigated using a protocol similar to the one 
previously used for iNOSoxy [4]. PN decay 
was followed by the variations in absorbance 
at 302 nm in the presence of 1.5 µM iNOSoxy 
and with increasing concentrations of PN (10, 
20, 50, 100, 200 µM). Three different 
experiments were recorded for each 
concentration. Several traces of the time-
dependent variation in absorbance at 302 nm 
were multi-fitted to mono-exponential 
functions using the Origin 6.0 software routine 
(OriginLab Corporation, Northampton, MA, 
USA). This protocol was repeated three times. 
The apparent rate constants thus obtained were 
averaged and plotted as a function of PN 
concentrations. The kinetics of PN decay 
catalyzed by saNOS at various PN 
concentrations were followed at 302 nm. The 
experimental details and the results are 
described in the Supporting information (Fig. 
S3). 
Kinetic analysis of heme spectral transitions – 
A 100 µM solution of PN was rapidly mixed 
with 4 µM of iNOSoxy at three different pHs 
(6.4, 7.4 and 8.4). This reaction was monitored 
at wavelengths characteristic of specific 
species and/or events depending on pH 
conditions, such as PN decay (302 nm), the 
ferric state of iNOSoxy (419 - 423 nm for the 
Soret band and 624 nm for the charge-transfer 
band) and the catalytic intermediate I435 (441 
- 447 nm). UV-visible absorption spectra were 
extracted from spectra vs time data sets at 
specific times to highlight defined transitions 
phases and to reveal complete PN 
consumption.  These spectra correspond to the 
initial and final states those at maximal 
concentration of intermediate(s). Difference 
absorption spectra were calculated from the 
initial and intermediate spectra to characterize 
the nature and extent of spectral changes at 
specific time points.  
Kinetics of build-up and decay of I435– Time-
dependent traces of the variation in absorbance 
at 445 nm were used to determine the time (t) 
at which the maximal concentration of 
iNOSoxy intermediate I435 was reached, i.e. 
between 200 to 300 ms, depending on the 
experimental conditions. The UV-Visible 
absorption spectrum of the intermediate I435 
was systematically calculated by subtracting 
from the spectrum at (t) an estimated fraction 
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that remained of the initial spectrum. This 
allowed us to estimate the wavelength 
maximum of the Soret band for intermediate 
I435 for each condition of pH and PN 
concentration. The apparent rates of build-up 
and decay of the intermediate I435 were 
obtained by analyzing the time-dependent 
traces of the increase (from 0 to 250 ms) and 
decrease (from 400 ms to the end of the 
kinetics) in absorption at this specific 
wavelength. These traces were fitted to a 
mono-exponential function to obtain apparent 
rates of build-up and decay. The same 
experiment has been achieved at several pHs 
from 6.2 to 8.4 and with 10-200 µM PN 
concentrations. The reported rates of build-up 
and decay of iNOSoxy I435 correspond to the 
average of three independent experiments. The 
kinetics of build-up and decay of I435 were 
also characterized using saNOS and various 
concentrations of PN. The data were fitted to a 
global three-state model involving the initial 
ferric enzyme (state A), I435 (state B) and 
final low-spin ferric (state C) states. The 
experimental details and the results appear in 
as Supporting information (Fig. S1, S2 and 
S3). 
Stoichiometric reaction of iNOSoxy with PN 
– A 60 µM PN solution was rapidly mixed 
with 60 µM iNOSoxy at 4 °C. The solutions 
were prepared to ensure a final pH of 7.4 after 
mixing. Superimposed spectra were analyzed 
to characterize heme spectral transitions. These 
were characterized by the presence of clear 
isobestic points. 
Resonance Raman characterization of 
reaction intermediates during early- and 
steady-state phases – To further characterize 
intermediate I435, a continuous-flow mixer 
[29] was used to obtain its resonance Raman 
spectrum in the high- and low-frequency 
regions. The resonance Raman spectra were 
acquired at 94 ms after mixing saNOS (50 µM)  
with PN (5 mM), in 100 mM KPi buffer pH 
6.4 + 300 M DTPA which corresponds to the 
time at which the maximal concentration of 
intermediate I435 was reached (Supplementary 
Fig. S1). The final pH of such mixed solution 
did not exceed 7.3. The equilibrium reference 
spectra of the Fe
III
 and Fe
III
NO complexes of 
saNOS were obtained in a Raman cell that was 
kept spinning to avoid local heating of the 
samples. The excitation wavelengths were the 
413.133 nm line of a Kr laser (Fe
III
) and the 
441.563 nm line of a He/Cd laser (Fe
III
NO and 
I435). 
The early phase of the reaction of saNOS with 
PN was probed 2.5 ms after mixing. Since 
I435 had not accumulated to a significant 
extent at such a short time after mixing, the 
optical spectrum had a Soret near that of the 
initial ferric state as determined from the 
stopped-flow kinetic data. Accordingly, the 
413.133 nm line of a Kr laser was used to 
acquire the resonance Raman spectrum in the 
early-phase in the high-frequency region. 
 
RESULTS 
Effect of pH on the kinetics of build-up of the 
I435 intermediate. A100 µM PN solution was 
rapidly mixed using a stopped-flow apparatus 
with 4 µM iNOSoxy in a degassed 0.1 M KPi 
buffer of pH values ranging from 6.2 to 8.4. 
Experimental and analytical procedures are the 
same as the ones described previously [4] (see 
Experimental Procedures). We observed, for 
each pH value, the build-up of the same 
intermediate that we and other teams 
previously described [4, 5]. The reconstructed 
absorption spectra of this I435 intermediate 
exhibited an apparent absorption maximum 
that shifted from 439.5 nm at pH 6.2 to 446 nm 
at pH 8.4 (not shown). All of the reconstructed 
spectra exhibited similar Q-band features at 
547-48 and 585-88 nm indicating that a similar 
intermediate species was being observed. We 
noted that the extent of I435 build-up, and its 
lifespan, significantly decreased as the pH 
increased. 
  
Figure 1: Analysis of the pH-dependence of the 
apparent rates of I435 build-up and decay. A 
100 µM PN solution was rapidly mixed with 4 µM 
iNOSoxy at 20 °C at pHs ranging from 6.2 to 8.4. The 
kinetic traces were fitted to a mono-exponential function 
to obtain the apparent rates of build-up and decay of 
I435. These apparent rates were plotted as a function of 
pH. Inset: The logarithmic plot of the rates of I435 build-
up vs pH was fitted to a simple model assuming one 
acido-basic couple with a pKa ~6.8. 
Kinetic traces showing I435 build-up and 
decay were monitored at the wavelength of 
I435 maximal absorption and were fitted to a 
mono-exponential function to get the apparent 
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rates of these transitions. The apparent rate 
constants were then plotted as a function of pH 
(Fig. 1, filled square). The rate of I435 decay 
was clearly pH independent. In contrast, the 
rate of I435 formation increased upon 
acidification of the solution up to a plateau. 
This behavior is characteristic of the 
involvement of an acido-basic equilibrium. 
The apparent pKa this transition was estimated 
at pH 6.8 from the logarithmic plot (Fig. 1, 
inset). Our results clearly suggest that the 
build-up of I435 involves at least one acido-
basic equilibrium. They also suggest that 
protonated peroxynitrite (PNH) is the actual 
reactive species. 
Effect of PN Concentration on the Kinetics of 
Formation of the Intermediate I435 and on 
the Kinetics of decomposition of PN. Aliquots 
of increasing concentrations of PN (from 12.5 
to 200 M final concentration) were rapidly 
mixed with iNOSoxy (1.5 M final 
concentration) in a degassed 0.1 M KPi buffer 
at pH 7.4. Stopped-flow experimental and 
analytical procedures were the same as 
described above. The spectral characteristics of 
the resulting intermediate I435 were the same 
for every PN concentration, i.e. the wavelength 
maximum of the Soret band was centered at 
ca. 443 nm (data not shown). 
 
Figure 2: Analysis of PN concentration-
dependence of the rates of I435 build-up and PN 
decay. Various concentrations of PN were rapid-mixed 
with 1.5 µM iNOSoxy in a freshly anaerobized KPi 
buffer at pH 7.4. Conditions as described under 
Experimental Procedures. Time traces recorded at 443 
nm (representative of I435 build-up) were fitted to a 
mono-exponential function. The apparent rate constants 
were then plotted as a function of PN concentration for 
I435 build-up (filled square) and for PN decay (open 
circle). Inset: The kinetic traces recorded at 443 nm that 
show the build-up of the intermediate I435 for the same 
increasing PN concentrations as the main figure. 
Kinetic traces of I435 build-up (Fig. 2, inset) 
were fitted to a mono-exponential function and 
the observed rate constants were plotted as a 
function of PN concentration (Fig. 2, main). 
The apparent rate of I435 formation increased 
linearly with the concentration of PN. The 
second order rate constant calculated from 
these data was 6.9 ± 0.5 x 10
4
 M
-1
s
-1
 at pH 7.4. 
This linear relationship indicates that a 
bimolecular reaction of PN with iNOSoxy 
controls the kinetics of formation of the 
intermediate I435. We also determined the 
kinetics of PN decomposition for increasing 
concentrations of PN (between 10 and 200 
µM) by analyzing directly PN decay at 302 
nm. The kinetic traces were fitted to a mono-
exponential function and the apparent rate 
constants were plotted as a function of PN 
concentration (Fig. 2, open circles). The rate of 
PN decomposition decreased as PN 
concentration increased, which is consistent 
with the larger extent of buildup of I435 
detected at higher PN concentrations (Fig. 2, 
insert). As the PN concentration increased, the 
rate of I435 formation increased but that of PN 
decay decreased, suggesting that distinct 
pathways characterize I435 build-up and PN 
decay.  
Stoichiometric reaction of PN with iNOSoxy. 
We then analyzed the profile of PN 
decomposition at stoechiometric PN/iNOSoxy 
ratio. A solution of 60 µM PN was rapidly 
mixed with a solution of 60 µM iNOSoxy at 
pH 7.4 using the same procedure described 
above (see Experimental procedures). PN 
decayed relatively rapidly with an apparent 
rate constant of 7.8 s
-1
, compared to 0.1 s
-1
 in 
the absence of iNOSoxy, which indicates that 
the vast majority of PN was decomposed as it 
reacted with iNOSoxy (Not shown). This 
apparent decay rate constant matches the one 
calculated using PN activation rate (kact = 
6.3±0.6 s
-1 
[4]). 
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Figure 3: Kinetic phases observed during PN 
activation by iNOSoxy at pH 6.4. A 100 µM PN 
solution was rapidly mixed with 4 µM iNOSoxy in a KPi 
0.1 M pH 6.4 buffer at 20 °C. Conditions as described 
under Experimental Procedures. Panel A. Main: The 
kinetic traces showing the variation in absorbance at 
characteristic wavelengths: 302 nm (red), 419 nm (blue), 
441 nm (black), 624 nm (green). Inset: calculated spectra 
of intermediates detected for steady-state assays at pH 6.4 
(black line) and for a reaction with a stoichiometric 
PN/iNOSoxy ratio at pH 7.4 (red line, see Experimental 
Procedures). Panel B. Superimposition of UV-visible 
absorption spectra that correspond to the successive 
intermediates observed during the early phase of PN 
activation by iNOSoxy at pH 6.4. Spectra at 3 ms (1), 12 
ms (2), 21 ms (3), 201 ms (4) and 4.35 s (final) are 
shown. 
Unlike what we observed under conditions of 
excess PN [4], only a small amount of the I435 
intermediate was observed (~7%, Fig. 3A, 
inset, red trace). This small build-up hints 
towards different mechanisms for PN 
decomposition between conditions of 
stoichiometric- and excess-PN.  
Successive Kinetic Phases of iNOS-induced 
PN Activation. We previously reported the 
existence of two distinct kinetic phases for the 
heme spectral changes during iNOSoxy-
induced PN activation at pH 7.4, characterized 
by the build-up and decay of the I435 
intermediate [4]. Since PN activation was 
faster at acidic pH [4], we investigated here the 
kinetics of iNOSoxy heme spectral changes at 
pH 6.4. Figure 3A shows the kinetic phases 
observed by stopped-flow optical absorption 
spectroscopy during activation of PN 
(100 µM) by 4 µM iNOSoxy in a degassed 
KPi buffer at pH 6.4 (see Experimental 
Procedures). Kinetic traces were monitored at 
characteristic wavelengths such as 302 nm (PN 
decay), 419 nm (ferric iNOS) and 441 nm 
(I435) and they suggest the existence of the 
same four phases that we reported at pH 7.4 
[4]. The initial-, intermediate- and final-UV-
visible absorption spectra are displayed in Fig. 
3B. Unexpectedly, the initial UV-visible 
absorption spectrum of iNOSoxy obtained 
right after mixing with PN (3 ms, Fig. 3B, 
Spectrum 1) exhibited a broad Soret band (95 
nm FWHM) with an apparent maximum 
centered around 404 nm and displayed an 
additional weak absorption at 650 nm, both of 
which are significantly different from the 
spectral features of native iNOSoxy, i.e. a 
wavelength maximum of the Soret band 
centered at ~419 nm (60 nm FWHM) and no 
absorption at 650 nm. The first observable 
kinetic phase (3  21 ms) is characterized by 
successive changes in the apparent wavelength 
maximum of the iNOSoxy Soret band 
(404409400 nm, spectra 2, 3) with a 
progressive loss in absorption intensity (greater 
than 20 %). The second phase (up to 200 ms) 
is characterized by the partial decay of the 
absorption at 318 nm and the concomitant 
build-up of an intermediate characterized by  a 
shoulder around 445 nm and the absence of the 
absorption band at 650 nm (Fig. 3B, Spectrum 
4). The third and fourth phases are similar to 
the ones described at pH 7.4 and correspond to 
the disappearance of the shoulder at 445 nm 
(up to 1.5 s) followed, after the complete 
consumption of PN, by a modification of ferric 
iNOSoxy that then displayed a Soret band 
centered at 411 nm and a new absorption band 
at 624 nm (data not shown).  
The major intermediate species observed at pH 
6.4 have very similar spectra features 
compared to the ones previously described at 
pH 7.4 [4]. However, we notice here the 
presence of several additional intermediate 
complexes in the initial phase of PN activation, 
which suggests an intricate interplay between 
iNOSoxy and PN that might involve different 
acido-basic forms of PN and heme 
intermediates. 
Characterization by Resonance Raman 
Spectroscopy of the intermediate(s) formed 
during the early- and steady-state phases of 
PN activation. To gain insight into the nature 
of the I435 intermediate and the early 
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intermediate(s), we turned to resonance Raman 
spectroscopy coupled with a rapid T-mixer to 
generate and probe these intermediates. Due to 
the large amount of protein required to carry 
out continuous-flow experiment [29], we used 
the bacterial NOS-like enzyme of 
Staphylococcus aureus, saNOS, which is well 
suited for those experiments and has been well 
characterized previously by steady-state and 
time-resolved resonance Raman spectroscopy 
[30, 31]. We first measured the apparent rate of 
PN decay achieved for iNOSoxy using this 
new model. The kinetics of I435 build-up and 
decay were characterized as well. Stopped-
flow optical spectroscopy experiments of the 
reaction of saNOS and PN show the transient 
build-up on a time-course of ~100 ms of 
intermediate I435. Global analysis revealed 
that the time-course of the overall reaction is 
characterized by main spectral contributions 
from three species which were the initial ferric 
state (Soret band at 398 m, mainly high-spin 
heme), I435 (Soret band centered at 440 nm) 
and the final ferric state (Soret band centered at 
418, mainly low-spin heme) (Supplementary 
Fig. S1). The analysis of the early phase of the 
reaction (1.5 to 12 ms) revealed a first optical 
transition characterized by an isosbestic point 
near 430 nm that is distinct from the isosbestic 
point at 423 that corresponded to the later 
formation of I435 (Supplementary Fig. S2). 
The detection of these two isosbestic points 
indicate that reactions other than the build-up 
of I435 take place in the early phase of the 
reaction of saNOS with PN. The kinetics of PN 
decay followed at 302 nm show that saNOS 
accelerates the decomposition of PN 
(Supplementary Fig. S3). As described for 
iNOSoxy, the rates of build-up and decay of 
I435, and the decay of PN, followed distinct 
patterns of dependence with respect to the 
concentration of PN (Supplementary Fig. S3). 
This whole profile, similar to that reported for 
bsNOS [5] and here with iNOSoxy, confirms 
that the properties of the reaction with PN are 
shared by all these NOSs and validates the use 
of saNOS to characterize I435. We then used 
resonance Raman spectroscopy coupled with a 
continuous flow T-mixer to characterize the 
I435 intermediate and to trap and identify any 
new reaction intermediates in the early phase 
of PN activation. The resonance Raman 
spectrum of the intermediate I435 was 
recorded in the high-frequency region 94 ms 
after mixing ferric saNOS (50 µM) with PN (5 
mM) to probe the heme core modes (See 
Experimental Procedures for the details). 
Figure 4A shows the resonance Raman spectra 
obtained for the PN/saNOS mixture 
(corresponding to I435), for the equilibrium 
Fe
III
NO species and for the native ferric 
enzyme. Notably, the 4 line of I435 (1376 cm
-
1
) was shifted by 3 cm
-1
 with respect to that of 
the ferric resting enzyme (1373 cm
-1
) and was 
nearly identical to that of the Fe
III
NO complex 
of saNOS (1375 cm
-1
). In the 1470-1510 cm
-1
 
region, the 3 lines characteristic of the 5C 
high-spin state (1489 cm
-1
) and of the 6C low-
spin state (1503 cm
-1
) were detected in the 
spectrum of ferric resting saNOS as reported 
previously [25]. In the spectrum of I435, the 3 
line at 1489 cm
-1
 that arises remaining ferric 
heme was much less intense and a new line 
centered at 1504 cm
-1
 was apparent. 
 Figure 4: Resonance Raman spectra of 
Intermediate I435. High-frequency- (A) and low-
frequency regions (B) of the resonance Raman spectrum 
of the intermediate I435 recorded 94 ms after mixing 
ferric saNOS with PN (FeIII + PN). The equilibrium 
reference spectra of saNOS in the ferric (FeIII) and 
FeIIINO states are also shown. The excitation 
wavelengths were 441.563 nm (FeIIINO and FeIII + PN) 
and 413.133 nm (FeIII).  
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This new 3 line displayed a frequency 
identical to that of the 3 line of the Fe
III
NO 
complex [31]. Additionally, the 1556 cm
-1 
(11) 
and 1575 cm
-1
 (2) lines of the Fe
III
NO 
complexes, which are not apparent in the 
resting Fe
III
 spectrum, are observed in the 
spectrum of I435. Overall, these results 
indicate that the heme core modes of I435 are 
very similar to those of the Fe
III
NO complex of 
saNOS.  
 
Figure 5: Analysis by resonance Raman 
spectroscopy of the early intermediate(s). The 
resonance Raman spectrum of the early intermediate(s) 
was acquired in the high-frequency region 2.5 ms after 
mixing ferric saNOS with PN. The excitation wavelength 
was 413.133 nm. The spectrum of ferric saNOS is shown 
as a reference. The difference spectrum calculated from 
these spectra is also shown (top trace) 
I435 was probe in the low-frequency region to 
obtain further evidence about its identity. The 
low-frequency region of resonance Raman 
spectra contains vibrational lines that provide 
information about the heme axial ligands as 
well as other lines that arise form in- and out-
of-the plane porphyrin vibrations [21, 22]. An 
intense line centered at 539 cm
-1
 was detected 
in the spectrum of I435 along with a shoulder 
near 550 cm
-1
 (Fig. 4B). A very intense line 
and a shoulder at the same frequencies were 
observed previously in the low-frequency 
region of the spectrum of the Fe
III
NO complex 
of saNOS and were assigned to the Fe-NO 
mode (539 cm
-1
) and Fe-N-O (553 cm
-1
) mode, 
respectively, based on the isotope shifts [32]. 
No other heme complex of saNOS is known to 
display such intense lines at these frequencies 
(half the intensity of 8 at 674 cm
-1
). The Fe-
OO mode of the oxygenated state of saNOS is 
at 517 cm
-1
 and its intensity is very small [29]. 
The frequency of the Fe-O stretching mode of 
the Cpd-II state was never reported for this 
protein. Such mode would be expected at a 
much higher frequency (near 790-800 cm
-1
) 
given the double-bond character of the Fe=O 
bond of an unprotonated ferryl state such as 
that of horseradish peroxidase [33, 34]  and 
myoglobin [35, 36]. If a putative Cpd-II of 
saNOS was protonated, like that of 
chloroperoxidase [37], the frequency could be 
near 565 cm
-1
, which is almost 30 cm
-1
 higher 
than the Fe-NO mode of saNOS. Other 
porphyrin lines at 683/684 and 751 cm
-1
 of 
I435 and Fe
III
NO have nearly identical 
frequencies and they are clearly different from 
those of the ferric resting saNOS spectrum 
(691 and 753 cm
-1
) (Fig. 4). Overall, the 
similarities of the porphyrin modes of I435 and 
of the Fe
III
NO complex, in both the high- and 
low-frequency regions, along with the 
detection of the intense Fe-NO and Fe-N-O 
modes in the time-resolved spectrum strongly 
indicates that I435 is a Fe
III
NO complex.  
We repeated this experiment but recorded the 
resonance Raman spectrum at 2.5 ms after 
mixing to probe the early phase the reaction of 
saNOS with PN. In this condition, the 
resonance Raman spectrum obtained in the 
high-frequency region was nearly identical to 
that of resting ferric saNOS (Fig. 5). This is 
consistent with the fact that I435 had not 
accumulated to a significant extent at that time 
as revealed from the stopped-flow data 
(Supplementary Fig. S1, Panel E). The 3 and 
4 region of the 2.5 ms spectrum (saNOS + 
PN) and that of ferric saNOS show a similar 
mixture of high- and low-spin states, which is 
reflected in the nearly flat difference spectrum 
calculated with these spectra (Fig. 5). The 
optical spectra recorded at 1.5-12 ms after 
mixing saNOS with PN display a slight blue-
shift with respect to the ferric resting state 
(Supplementary Fig. S2). As describe above, a 
clear isosbestic point, different from the one 
that characterizes the build-up of I435, is also 
observed in the early-phase of the reaction. 
Although these results suggest the formation of 
an early intermediate, resonance Raman 
spectroscopy failed to detect its spectral 
fingerprints possibly because this intermediate 
did not accumulate to a level high enough to 
allow its detection. 
 
DISCUSSION 
Kinetic Analysis of the Interaction between 
PN and NO-Synthases. The interaction of PN 
with hemo-thiolate proteins has been the focus 
of numerous reports in the last twenty years. 
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Analysis of such reactions by stopped-flow 
optical spectroscopy and steady-state assays [7, 
9] led to evidence of the build-up of a heme 
complex that display spectroscopic fingerprints 
similar to those of the chloroperoxidase 
Compound II (Cpd-II) complex. The 
interaction of PN with various hemo-thiolate 
proteins consistently led to an increased in the 
level and complexity of the nitration pattern of 
PN, suggesting the release of nitrogen dioxide, 
NO2° [11]. As consequence, the simplest 
model to account for these observations 
proposed that  the reaction of PN with hemo-
thiolate proteins results in the homolytic 
cleavage of the PN O-O bond  leading to a 
[Cpd-II NO2°] caged pair (Scheme 1, red 
arrows). However, several pieces of 
information suggest that the observed reactions 
might not directly correspond to the sole 
activation of PN by the heme.  
First, the kinetics of PN/NOS interaction seem 
to change depending on the molar ratio 
between PN and NOS. In conditions that were 
standardly used in previous reports, i.e. when 
PN is in excess (100 µM PN for 2 µM NOS) 
we observed (here and in previous reports[4]) a 
strong build-up of the I435 intermediate. 
However, using a stoichiometric PN/NOS 
ratio, we did observed the strong acceleration 
of PN decay but only negligible I435 build-up. 
Reciprocally, as the PN concentration 
increased, we observed that the extent and rate 
of I435 build-up increased whereas the rate of 
PN decay decreased. This divergent pattern 
suggests that at least two modes of PN 
decomposition might co-exist: one fast mode at 
low PN/iNOSoxy molar ratio that does not 
necessarily involve I435 formation, and one 
slow mode at high PN/iNOSoxy molar ratio 
that leads to I435 build-up.  
The fast mode corresponds likely to the 
reaction of PN with the NOS ferric heme and 
does not seem to engage I435 buildup. The 
slow mode is characterized by the build-up of 
the I435 intermediate and might involve 
additional side-reactions of PN with other 
heme intermediates or with RNS end-products. 
This hypothesis of multiple PN decomposition 
routes has been already envisioned for metallo-
porphyrins [38] and metallo-proteins [1]. 
Cross-reactions of PN with the Compound I- 
or Compound II intermediates [39-42] [43] but 
also iron-oxo [44-47] and iron-nitrosyl 
complexes [42, 48, 49] have been commonly 
proposed.  
Thus, the activation of PN - as seen by the 
acceleration of its decay – is not univocally 
linked to I435 formation, which, in turn, could 
correspond to reaction intermediates different 
from oxoferryl species.  
Nature of the NOS intermediate I435 
observed during the activation of PN. The 
nature of the I435 intermediate has been from 
the beginning the key element for proposing 
the mechanism of interaction of PN with 
hemo-thiolate proteins. In this regard, the 
similarity between the spectroscopic 
fingerprints of I435 and oxoferryl complexes 
has led the first research groups to assign this 
reaction intermediate to a Cpd-II-like species 
[12, 13]. More recently Newcomb and 
coworkers used X-Ray absorption 
spectroscopy to identify the reaction 
intermediate observed upon interaction of PN 
with cytochrome P450 as a Cpd-II species 
[13]. The photo-oxidation of this intermediate 
apparently gave rise to the build-up of a Cpd-I 
species [14, 17, 50, 51], alike what was 
reported for chloroperoxidase [16]. Such 
species showed some competency for 
substrates oxidation reinforcing the first 
assignment of I435 as an oxoferryl 
intermediate. Moreover, the Newcomb’s group 
recently reported a similar kinetic behavior for 
a putative Cpd-I generated with m-
chloroperoxybenzoic acid and for that obtained 
from the photoreduction of I435 generated by 
the reaction with PN [52]. However, this dual 
assignment (Cpd-I and Cpd-II complexes) was 
challenged by Green and coworkers. Indeed, 
the Green’s group did not observe the same 
spectroscopic fingerprints for the Cpd-I species 
of P450 [53, 54]. Second, using Mossbauer 
spectroscopy, they suggested that the initial 
I435 intermediate would not be a Cpd-II but 
rather an iron-nitrosyl species. However, the 
differences in the Mossbauer parameters for all 
these compounds remain minor and in the 
absence of additional spectroscopic 
characterization of the I435 intermediate, the 
dispute might go on [52, 55]. 
In this context, our report brings a novel and 
definitive piece of evidence concerning the 
nature of the I435 intermediate. Using time-
resolved resonance Raman spectroscopy and 
stopped-flow/UV-visible spectroscopy, I435 
was obtained and probed in the same 
experimental conditions, and can thus be 
directly compared. We did not observe any 
signal corresponding to an oxoferryl complex 
at the reaction time corresponding to maximal 
I435 build-up. Instead, the frequencies of the 
porphyrin vibrational modes and the strong Fe-
N vibrational mode are the clear signature of a 
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Fe
III
NO species. As resonance Raman 
spectroscopy is one of the best suited method 
to probe NO coordination to hemoproteins, our 
results strongly indicate that the I435 
intermediate is most likely to be a Fe
III
NO 
complex. Our results also indicate that such a 
complex arises from secondary reactions 
involving excess PN. In this environment, the 
Fe
III
NO complex is not stable and decays back 
to the ferric state within seconds suggesting 
that I435 disappearance may be linked to other 
secondary reactions as well. How 
photoreduction of such a complex mixture may 
trap a Cpd-I state at relatively high-yield is not 
clear [52, 55]. Beyond the dispute between the 
Newcomb’s and Green’s groups concerning 
the spectroscopic fingerprints of Cpd-I and 
Cpd-II complexes, the major outcome of our 
work concerns the reaction of PN with 
hemoproteins and the link between PN 
activation and I435 intermediate formation. In 
this regard, our results call into question the 
current mechanism, which proposes that I435 
formation arises from the homolytic cleavage 
of PN O-O bound. 
Relationship between PN activation and 
build-up of the I435 intermediate. NOS 
isoforms represent a good investigative model 
of the reaction of PN with hemoproteins. 
Indeed, despite the similar 3D structure of their 
catalytic site, they exhibit different interaction 
profiles with PN. Although all NOSs undergo 
reactions that result in the build-up of 
intermediate I435, these reactions when looked 
at biochemically lead either to an enhanced 
nitration pattern by PN (iNOS) or to the 
scavenging of PN (bsNOS) [5]. The reason 
why the same proposed mechanism of 
activation, that involves PN homolytic 
cleavage and NO2° release, could lead to 
different outcomes for PN reactivity has 
remained unexplained so far.  
Our results indicate that the build-up of I435, 
which is Fe
III
NO complex, is not the landmark 
of PN homolytic cleavage and the formation of 
a [Cpd-II / NO2°] cage pair. Thus the persistent 
build-up of I435 observed for all NOSs might 
be related to side-reactions, whereas the 
reactions that truly correspond to PN activation 
– and that remain unexplored - might differ 
among NOS isoforms. 
The mechanism of activation of heme-bound 
PN can be derived from former investigations 
that concern the reactions of NO dioxygenation 
by oxyhemoglobin [56]. Indeed, this reaction is 
believed to lead to a heme-bound PN complex, 
that will eventually undergo a homolytic 
cleavage, leading to the formation of a [Cpd-II 
/ NO2°] cage pair. This step would be followed 
by a direct recombination of NO2° on the 
oxoferryl complex, resulting in the 
isomerization of PN and the release of nitrate 
[57] (Scheme 1, green arrow). The formation 
of PN-heme complex is believed to take place 
within 1 ms of PN interaction with the heme 
[58] and might in fact even be too fast to be 
observed [59].  
In the case of NOSs (and other hemo-thiolate 
proteins), these reactions should even be faster 
giving the greater reactivity of their heme 
conferred by the elevated electronic "push" 
capacity from the thiolate bond. Thus the 
intermediates involved in PN activation by 
NOSs might be too transient to be observed. 
Our stopped-flow results are consistent with 
this proposal; the first- and other early-
spectroscopic fingerprints seem to indicate that 
a sequence of reactions had already taken place 
within the dead-time of our rapid-mixing 
device and in the first milliseconds of the 
observed kinetics. This may indicate that the 
first observed optical absorption spectrum does 
not correspond to the native resting enzyme 
and that the homolytic cleavage reaction may 
already be completed. However the time-
resolved resonance Raman investigation of the 
initial kinetic event(s) only revealed the 
presence of the porphyrin modes characteristic 
of the ferric species and did not show any 
additional feature that may originate from 
intermediates. It may be that these 
intermediates do not accumulate to a 
sufficiently level to be detected.  
Formation and decay of a Fe
III
NO complex. 
As we demonstrated that the I435 intermediate 
does not arise directly from the homolytic 
cleavage of the PN O-O bond, the question of 
its formation arises. There are two possible 
scenarios: i) an alternative mechanism of PN 
decomposition. In this scenario, PN binds to 
the native heme but the active intermediate 
would correspond to a N-bound PN complex 
that could experience an homolytic N-O bond 
cleavage leading to the formation of Fe
III
NO 
(Scheme 1, blue arrows) and the release of 
superoxide anion (O2°
-
). The dissociation rate 
of free PN (NO/O2°
-
,[60]) has been estimated 
to be around 0.017 s
-1
, which is far below the 
rates of PN decay observed in these 
experiments (between 0.1 and 2 s
-1
 depending 
on the conditions). Thus one could conceive 
that heme speeds up the cleavage of the N-O 
bond of PN, accounting for the increased rate 
of PN decomposition. ii) NO rebinding. In this 
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second scenario, PN decomposition through 
various paths will eventually lead to the 
accumulation of NO as a side-product that will 
bind to free heme and shift the steady-state 
equilibrium towards the transient accumulation 
of Fe
III
NO. There are almost no observations 
related to these hypotheses, and further 
experiments are required to help understand 
the mechanism of formation of a heme-NO 
complex out of PN decomposition.  
Conclusion. Our results unambiguously show 
that the crucial intermediate observed in the 
reaction of PN and hemo-thiolate proteins, 
believed to be a Compound II species, is not an 
oxoferryl complex but a Fe
III
NO complex. Its 
build-up is not linked to the homolytic 
cleavage of the PN O-O bond but arises from 
side-reactions associated with the presence of 
excess of PN. The enhanced nitration patterns 
resulting from heme-induced PN activation is 
disconnected from I435/Fe
III
NO build-up. New 
experiments and concepts are now needed to 
investigate the details of PN activation 
mechanism. In this regard, NO-synthase 
isoforms represent a good model to correlate 
the mechanism of O-O bond activation and the 
biological fate of PN.  
 
SUPPORTING INFORMATION 
Supplementary Fig. S1. Global analysis using 
a three-state model (A→B→C) of optical 
absorption spectra versus time data sets of the 
reaction of saNOS with PN. 
Supplementary Fig. S2. Early-phase of PN 
activation by saNOS. 
Supplementary Fig. S3 PN concentration-
dependence of the apparent rates of I435 build-
up and decay, and of the apparent rate of PN 
decay, that are catalyzed by saNOS. 
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The abbreviations used are: Arg, L-arginine; Cpd-I and Cpd-II, Compound I and II in 
chloroperoxidase and catalase catalytic cycle ; DHR, dihydrorhodamine; DTPA, 
diethylenetriaminepentaacetic acid; FAD, flavin adenine dinucleotide; FMN, flavin adenine 
mononucleotide; FNR, Ferredoxin-NADP-Reductase; FeIINO, ferrous heme-nitric oxide complex; 
Fe
III
NO, ferric heme-nitric oxide complex; Fe
II
CO, ferrous heme-carbon monoxide complex; H4B, 
tetrahydrobiopterin, (6R)-5,6,7,8-tetrahydro-L-biopterin; Hb, hemoglobin; Mb, myoglobin; KPi, 
inorganic phosphate buffer; NADPH, Nicotinamide Adenine Dinucleotide Phosphate reduced form; 
NO, nitric oxide; NOHA, N

-hydroxy-L-arginine, NOS, nitric oxide synthase; NOSoxy, oxygenase 
domain of NOS; eNOS, endothelial nitric oxide synthase; iNOS, inducible nitric oxide synthase; 
nNOS, neuronal nitric oxide synthase; bsNOS, NOS-like protein isolated from Bacillus subtilis; 
saNOS, NOS-like protein isolated from Staphylococcus aureus, P450BM3, cytochrome P450 CYP120 
isolated from Bacillus megaterium; P450Cam, camphor 5-monoxygenase isolated from Pseudomonas 
putida; PN, peroxynitrite anion; PNH, peroxynitrous acid; ROS, Reactive Oxygen Species; RNS, 
Reactive Nitrogen Species. 5C, 5-coordinate state of the heme; 6C, 6-coordinate state of the heme 
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